Fractyl Health, Inc. (GUTS)
(Delayed Data from NSDQ)
$4.36 USD
+0.03 (0.69%)
Updated Jun 26, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Price, Consensus and EPS Surprise
GUTS 4.36 +0.03(0.69%)
Will GUTS be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for GUTS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for GUTS
Bank of America Securities Reaffirms Their Buy Rating on Fractyl Health, Inc. (GUTS)
Fractyl Health price target lowered by $4 at BofA, here's why
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
Fractyl Health Updates Clinical Studies and Corporate Slides
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates